Found: 41
Select item for more details and to access through your institution.
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evolution of Herpes Zoster Vaccines and Their Economic Value.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Barriers for integrating personalized medicine into clinical practice: A qualitative analysis.
- Published in:
- American Journal of Medical Genetics. Part A, 2013, v. 161A, n. 4, p. 758, doi. 10.1002/ajmg.a.35811
- By:
- Publication type:
- Article
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 442, doi. 10.1111/dom.14593
- By:
- Publication type:
- Article
Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046746
- By:
- Publication type:
- Article
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2237606, doi. 10.1001/jamanetworkopen.2022.37606
- By:
- Publication type:
- Article
General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice Experiment.
- Published in:
- Patient, 2019, v. 12, n. 2, p. 235, doi. 10.1007/s40271-018-0329-1
- By:
- Publication type:
- Article
The independent contribution of executive functions to health related quality of life in older women.
- Published in:
- BMC Geriatrics, 2010, v. 10, p. 16, doi. 10.1186/1471-2318-10-16
- By:
- Publication type:
- Article
Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2342264, doi. 10.1001/jamanetworkopen.2023.42264
- By:
- Publication type:
- Article
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1002/edm2.103
- By:
- Publication type:
- Article
Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 2, p. 824, doi. 10.1002/cam4.2735
- By:
- Publication type:
- Article
Technical Note: Acceptability Curves Could Be Misleading When Correlated Strategies Are Compared.
- Published in:
- Medical Decision Making, 2008, v. 28, n. 3, p. 306, doi. 10.1177/0272989X07312726
- By:
- Publication type:
- Article
Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE).
- Published in:
- BMC Health Services Research, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6963-13-454
- By:
- Publication type:
- Article
Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Cost Effectiveness of Herpes Zoster Vaccine in Canada.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 12, p. 991, doi. 10.2165/11314010-000000000-00000
- By:
- Publication type:
- Article
High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 126, doi. 10.1002/cpt.3080
- By:
- Publication type:
- Article
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 853, doi. 10.1002/cpt.2983
- By:
- Publication type:
- Article
Cost to Medicare of Delayed Adalimumab Biosimilar Availability.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 1050, doi. 10.1002/cpt.2322
- By:
- Publication type:
- Article
Using Real‐World Data to Extrapolate Evidence From Randomized Controlled Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 5, p. 1156, doi. 10.1002/cpt.1210
- By:
- Publication type:
- Article
Simulation for Predicting Effectiveness and Safety of New Cardiovascular Drugs in Routine Care Populations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 1008, doi. 10.1002/cpt.1045
- By:
- Publication type:
- Article
Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 914, doi. 10.1002/cpt.873
- By:
- Publication type:
- Article
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A bronchial‐airway gene‐expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost‐effectiveness analysis.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 3, p. 781, doi. 10.1002/ijc.32333
- By:
- Publication type:
- Article
Competition and price among brand-name drugs in the same class: A systematic review of the evidence.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Competition and price among brand-name drugs in the same class: A systematic review of the evidence.
- Published in:
- PLoS Medicine, 2019, v. 16, n. 7, p. 1, doi. 10.1371/journal.pmed.1002872
- By:
- Publication type:
- Article
A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 11, p. 1172, doi. 10.1002/pds.1994
- By:
- Publication type:
- Article
Comparing different experimental designs for best-worst scaling choice experiments: the case of asthma control.
- Published in:
- International Journal of Health Preference Research (IJHPR) / Revue Internationale de Recherche sur les Préférences en Santé, 2018, p. 3, doi. 10.21965/IJHPR.2018.001
- By:
- Publication type:
- Article
Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus.
- Published in:
- Annals of Internal Medicine, 2015, v. 162, n. 6, p. 407, doi. 10.7326/M14-1152
- By:
- Publication type:
- Article
Exact sequential analysis for multiple weighted binomial end points.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Common non‐cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 10, p. 3179, doi. 10.1111/jgs.18479
- By:
- Publication type:
- Article
Restricted mean survival time versus conventional measures for treatment decision‐making.
- Published in:
- Journal of the American Geriatrics Society, 2021, v. 69, n. 8, p. 2282, doi. 10.1111/jgs.17195
- By:
- Publication type:
- Article
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2024, v. 47, n. 11, p. 1900, doi. 10.2337/dc24-0270
- By:
- Publication type:
- Article
Increasing incidence associated with herpes zoster infection in British Columbia, Canada.
- Published in:
- BMC Infectious Diseases, 2016, v. 16, p. 1, doi. 10.1186/s12879-016-1898-z
- By:
- Publication type:
- Article
Sustained Economic Benefits of Resistance Training in Community-Dwelling Senior Women.
- Published in:
- Journal of the American Geriatrics Society, 2011, v. 59, n. 7, p. 1232, doi. 10.1111/j.1532-5415.2011.03474.x
- By:
- Publication type:
- Article
320-OR: Cardiovascular Effectiveness of Empagliflozin in Patients with and without Cardiovascular Disease.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-320-OR
- By:
- Publication type:
- Article
792-P: Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-792-P
- By:
- Publication type:
- Article
134-LB: Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-134-LB
- By:
- Publication type:
- Article
133-LB: Cardiovascular Outcomes in Older Adults Initiating Empagliflozin vs. DPP-4 Inhibitors and GLP-1 Receptor Agonists: A Subgroup Analysis from the EMPRISE Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-133-LB
- By:
- Publication type:
- Article
1193-P: Health-Care Costs and Medication Burden in Routine Care Initiators of Empagliflozin: A First Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1193-P
- By:
- Publication type:
- Article
249-OR: Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-249-OR
- By:
- Publication type:
- Article